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INTRODUCTION
Neisseria meningitidis is a leading cause of bacterial menin-
gitis and septicemia among children and young adults (1).
The annual incidence of meningococcal disease in the U.S.A.
was 0.8-1.0 per 100,000 population during 1992-1996 (1).
In European countries, the overall incidence of meningococcal
disease was 1.1 per 100,000 population during 1993-1996
(2). Northern European countries tend to have a higher rate
of incidence (2). The annual incidence in Norway, for exam-
ple, was 2.4-4.6 per 100,000 population during 1992-1995
(3). The majority of cases are sporadic and due to serogroups B
and C in the U.S.A. and Europe (4). In China and the African
‘meningitis belt’, the annual incidence due to serogroup A
is more than 500 per 100,000 population during epidemic
periods (5). In Korea, however, data of the incidence and
serogroups of meningococcal disease are not yet available.
Military personnel are considered to have a higher risk for
meningococcal disease than the civilian population. The
increased risk is probably related to crowded living condi-
tions among the people from various geographic areas, as well
as to the specific age group (6). In the U.S. Army, the rate of
hospitalizations resulting from meningococcal disease was
25.2 per 100,000 population during 1964-1970, and as a
result vaccination campaigns were begun in 1971. During
1990-1998, the overall rate of hospitalizations from meningo-
coccal disease among the enlisted, active-duty service mem-
bers of the U.S. Army was 0.5 per 100,000 population (6).
In the Republic of Korea Army, the need for meningococ-
cal vaccination was not considered because data of the inci-
dence and serogroups were not available. Thus, this study was
performed to determine the incidence and serogroups of
meningococcal disease in the Korean Army.
MATERIALS AND METHODS
We identified the prospective cases of meningococcal menin-
gitis or septicemia that occurred in Armed Forces Capital
Hospital (AFCH) from August 2000 to July 2001. AFCH
is the final referral medical center in the Korean Army. The
computerized database of the Armed Forces Medical Com-
mand (AFMC) was examined retrospectively to identify addi-
tional cases from other Korean military hospitals during the
same periods. In the Korean Army, individual cases of com-
municable disease including meningococcal disease are com-
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Meningococcal Disease in the Republic of Korea Army:
Incidence and Serogroups Determined by PCR
This study was performed to determine the incidence and serogroups of meningo-
coccal disease in the Korean Army. From August 2000 to July 2001, we identi-
fied prospective cases in the Korean Army. Meningococcal disease was con-
firmed by isolation of Neisseria meningitidis or detection of its antigen by latex
agglutination from cerebrospinal fluid (CSF) or blood. Polymerase chain reac-
tions (PCRs) were performed in the crgA gene to identify N. meningitidis regard-
less of its serogroup, and then in orf-2 (serogroup A) and siaD (serogroups B, C,
Y, and W135) respectively for serogroup prediction. During the study period, twelve
patients (four meningitis and eight septicaemia) were identified. The annual inci-
dence was 2.2 per 100,000 (95% confidence interval, 1.3-3.8) among 550,000
private soldiers. Latex agglutinations were positive to A/C/Y/W135 polyvalent
latex, but not to B latex in all patients. PCRs of crgA gene were positive in ten
patients, whose samples (2 isolates from CSF, 2 CSFs, and 6 sera) were stored.
In PCRs for serogroup prediction, one isolate was serogroup A, and one isolate
and two sera were serogroup C. The need for meningococcal vaccination would
be considered in the Korean Army through the cost-benefit analysis based on
the result of this study. 
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pulsory notifiable to the Department of Preventive Medicine,
AFMC. We defined an outbreak as 3 or more cases of menin-
gococcal disease occurring within a 3-month period among
the residents of a camp. The incidence was defined as cases per
100,000 population per year among 550,000 private soldiers.
The definition of meningococcal disease was based on clini-
cally compatible symptoms or purpura fulminans with the
identification of N. meningitidis or its antigen from cere-
brospinal fluid (CSF) or blood. Identification of N. meningi-
tidis was done using the Vitek system (bioMerieux-Vitek,
U.S.A.). The detection of meningococcal antigen was done
by latex agglutination test (Murex, Wellcome Diagnostics
Limited, Dartford, U.K.) from CSF or serum. The test was
performed according to the protocol of the manufacturer. This
commercial kit consists of polyvalent latexes for serogroups
A/C/Y/W135, serogroup B/Escherichia coli K1, or the posi-
tive control. The positive result is defined as a clear aggluti-
nation of single test latex accompanied by negative reactions
with all other test latex reagents. 
The meningococcal isolates, CSF, or serum from patients
of AFCH were stored at -70℃. These samples were taken at
the time of the hospital admission. Serogrouping by PCR
was performed on available samples by using the methods
described previously (7). To identify N. meningitidis, regardless
of its serogroup, a PCR screen was performed in the crgA
gene. This gene is involved in the regulation of adhesion of
N. meningitidis to target cells (7). For serogroup prediction,
PCRs were performed with oligonucleotides in the orf-2 gene
(serogroup A) and in the siaD gene (serogroups B, C, Y, and
W135), respectively. The sizes of the expected amplicons
from these PCRs were 230 bp (crgA), 400 bp (serogroup A),
450 bp (serogroup B), 250 bp (serogroup C), and 120 bp
(serogroups Y and W135) (7).
RESULTS
During the study period of one year, a total of twelve patients
with meningococcal disease have diagnosed in AFCH, in-
cluding ten patients who transferred from other military
hospitals in Korea. A review of the database of the AFMC
showed that there were no patients with meningococcal dis-
ease in other hospitals, who were not transferred to AFCH.
The annual incidence was 2.2 per 100,000 population (95%
confidence interval, 1.3-3.8). Five of the twelve patients
occurred in February 2001, but there was no outbreak during
the study period (Table 1).
All twelve patients were male. The median age of patients
was 21 yr old (ranged, 19-22 yr). The median interval between
the enlistment and the first symptom was 80 days (ranged,
17-553 days). Of the twelve patients, four were diagnosed
as meningitis, six as septicemia only, and two as septicemia
with meningitis. Eight patients with  septicemia were ad-
mitted to AFCH within 24 hr after the first symptom, and
four patients with meningitis were admitted within 1-4 days.
Two patients with septicemia accompanied by multiorgan
dysfunctions died at eighth and fifteenth hours, respectively,
after the purpura fulminans (Table 1). These two patients
had been treated for meningococcal meningitis during six
and fifteen months previously, respectively, in AFCH. Com-
plications developed in four patients. Skin necrosis with sec-
ondary infection occurred in two patients (Cases 3 and 11). In
Case 11, reconstructive skin surgery was done on nearly the
whole area of both lower extremities. In Case 6, right deltoid
muscle weakness developed and resolved 3 months later. As
sequelae of frontal lobe dysfunction, partial loss of memory
and cognition power remained in Case 9. 
Latex agglutinations were positive to serogroups A/C/Y/
W135 polyvalent latex, but not to serogroup B/E. coli K1
latex in all patients. Two of the twelve patients were exclud-
ed due to sample loss (Cases 4 and 5). In ten patients whose
samples were stored (2 isolates from CSF, 2 CSFs, and 6 sera),
PCRs of the crgA gene were positive at 230 bp (Fig. 1A). In
PCRs for serogroup prediction, one isolate (Case 12) was
serogroup A (orf-2, 400 bp), and one isolate (Case 9) and
two sera (Cases 7 and 10) were serogroup C (siaD, 250 bp)
(Fig. 1B). In other patients (2 CSFs and 4 sera), serogroups
could not be determined by PCR. Consequently, we could
not determine a serogroup by PCR in six patients, however,
there were no cases of serogroup B. 
1 Aug. septicemia DIC alive
2000
2 Sep.  septicemia coma, shock, DIC death (15 hr after
2000 purpura)
3 Oct. septicemia DIC skin  necrosis
2000
4 Jan. meningitis alive
2001
5 Feb. both drowsy,  shock alive
2001
6 Feb.  both drowsy, ARF right deltoid myopathy
2001
7 Feb. septicemia alive
2001
8 Feb. meningitis drowsy alive
2001
9 Feb.  meningitis drowsy frontal lobe dysfunction
2001
10 Mar.  septicemia coma, shock, DIC, death (8 hr after 
2001 ARF purpura)
11 May  septicemia DIC skin grafts on both 
2001 lower limbs
12 Jun. meningitis drowsy alive
2001
Case Date Diagnosis Organ dysfunctions Outcomes*
Table 1. Outcomes of patients with meningococcal disease
Both: septicemia with meningitis; DIC: disseminated intravascular coa-
gulopathy; ARF: acute renal failure. *Alive, (alive with) complication, or
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DISCUSSION
In Korea, data for the incidence and serogroups of meningo-
coccal disease were not available in military, as well as in
civilian population. This study is the first report in Korea
despite the data during introduced only a year ago. In the
U.S. Army, rates of meningococcal disease have decreased
since the early 1970s. However, this was not the only effect
of vaccination campaigns. The rates in U.S. Army personnel
declined before the 1971 vaccination campaigns, suggesting
that the smaller recruit populations at training installations
and the natural periodicity of outbreaks may have contributed
to the decline in the disease (6). However, routine vaccina-
tion of high-risk populations may be a reasonable public
health strategy because meningococcal disease may be fatal
and fulminant. Routine vaccination for controlling meningo-
coccal disease would be considered in the Korean Army. 
A specific group that has several characteristics found com-
mon among the military personnel is college students, espe-
cially dormitory residents. Recently, the reports of meningo-
coccal disease on college campuses have increased in the
U.S.A. and the United Kingdom (6, 8). The U.S.A. surveil-
lance data from 1998 to 1999 school year suggested that
the overall rate of meningococcal disease among the college
students with dormitory resident was higher than the rate
among the same age-group people between persons aged 18
to 23 yr who were not enrolled in college: 2.2 vs. 1.5 per
100,000 (6). The annual incidence in the Korean Army was
2.2 per 100,000 population in this study. This is the same
as the incidence of dormitory residents of U.S.A. colleges.
In this study, there was no serogroup B disease in latex
agglutination test. A serogroup B meningococcal vaccine is
not available. The immunnogenicity and clinical efficacy of
serogroup A and C vaccines have been well established in
young adults (9, 10). The bivalent (A/C) or quadrivalent
(A/C/Y/W135) meningococcal vaccine may be effective in
the Korean Army. Recently in the U.S.A., there have been
conflicting opinions as to whether college freshmen should
be targeted for routine vaccination (6, 11, 12). Vaccination
of all freshmen or the specific freshmen who live in dormi-
tories is unlikely to be cost-effective (6). In a military recruit
camp, however, the cost of vaccination may be reduced because
of the method of mass administration. 
Serogroups of six patients could not be determined by PCR
in this study. This was because the sensitivity of nonculture
based PCR from CSF or serum was low, not because there
were serogroups other than A, B, C, Y, or W135 in this study.
Many of our samples were of ‘category 2’ of the original
method referenced: culture was negative but antigen detec-
tion for N. meningitidis was positive (7). As a result of the
reference, the sensitivity of CSF of category 2 was 92% and
the sensitivity of serum was 71%. In this method, CSF and
serum were heated at 100℃for 3 min and centrifuged, then
PCR was done. If we performed the procedures of purifica-
tion of nucleic acids from samples, the sensitivity might be
increased (13).
The two patients who died in this study had two episodes
of meningococcal disease within six or fifteen months, respec-
tively. Because the first episodes of the two patients occurred
before this study period, we could not confirm whether the
second episodes were relapses or reinfections. Also, we could
not document whether these patients had chronic meningo-
coccemia with complement deficiencies, because they died
with septic shock and multiorgan dysfunctions within a few
hours after the admission. In a case report of 112 meningo-
coccal infections at the U.S. Army training center, two patients
had experienced two or three episodes within four or eight
month periods (14). Although a specific antibody against N.
meningitidis is generally protective, this immunity is not
absolute (15, 16). Feldman believed that at least four infec-
tions are possible because the acquired immunity is group-
specific (17). 
In summary, a total of twelve patients of meningococcal
disease occurred in the Korean Army from August 2000 to
Fig. 1. PCR amplification of the crgA gene. The sizes of crgA amplicons are 230 bp (A). Serogroup specific PCR of the orf-2 and siaDs.
The size of orf-2 (serogroup A) amplicon is 400 bp. The size of siaD amplicon for serogroup C is 250 bp (B). The lane name is case num-
ber+specimen: S= serum, C= cerebrospinal fluid, and M= microorganism. Lane (‐)is the negative control. Size markers (100 bp ladder)
are indicated in base pairs at the right.
A B
(‐)    1S    2S   3S    6C   7S    8C   9M  10S  11S 12M
(‐)     7S          9M  10S  12M
230
400
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July 2001. The annual incidence was 2.2 cases per 100,000
population (95% confidence interval, 1.3-3.8). We identified
one serogroup A and three serogroup C diseases by PCR
among ten patients whose samples were stored. However,
there was no serogroup B disease found by latex agglutina-
tion tests. The need for meningococcal vaccination would
be considered in the Korean Army through the cost-benefit
analysis based on this study’s results.
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